Header Logo

Connection

DEEPIKA SATISH to Infliximab

Back to Details
This is a "connection" page, showing publications DEEPIKA SATISH has written about Infliximab.
DEEPIKA SATISH
Connection Strength
0.180
Infliximab
  1. Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study. J Immunother Cancer. 2021 11; 9(11).
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.